A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

Condition:   Advanced Breast Cancer Interventions:   Drug: SHR6390;   Drug: Placebo;   Drug: Fulvestrant Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials